NCT06151574

AUG 20, 2026 · PHASE 3 TRIAL

Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

ClinicalTrials.gov

This is a Phase 3 RCT registration with no results posted; the study is active but not yet recruiting and outcomes have not been reported, making it a planned trial rather than evidence of efficacy.